TUDCA (Tauroursodeoxycholic acid)
Bile acid derivative studied in liver diseases; bodybuilders use it as a “liver protector”, but this has not been studied directly.

The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

DETAILED OVERVIEW
What is TUDCA (Tauroursodeoxycholic acid)?
TUDCA (tauroursodeoxycholic acid) is a bile acid derivative: the taurine-bound, more water-soluble form of ursodeoxycholic acid. Controlled human trials have been done with it in liver diseases with blocked bile flow and in liver cirrhosis. Whether it is sold as a dietary supplement or a prescription medicine differs by country; it is not on the anti-doping list.
It pushes out the water-repelling bile acids that damage liver cells, which improves bile flow; whether it can reduce stress inside cells is also being researched, but no conclusion for humans can be drawn yet. In the bodybuilding community it has spread as a “steroid liver protector”, but this role has not been studied directly in humans: there is no trial showing that it prevents liver damage from steroids taken by mouth. The protective effect is only an assumption: it does not make steroids safe, and it does not replace monitoring of liver enzymes. Its most common side effect is diarrhea. It is contraindicated in complete blockage of the bile ducts and in acute gallbladder inflammation; in pregnancy and breastfeeding there is little safety data.
What it is
The taurine-conjugated, water-soluble bile acid derivative of ursodeoxycholic acid.
Evidenced area
Cholestatic liver disease and cirrhosis, with randomized human data.
Unevidenced area
Prevention of 17-alpha-alkylated steroid liver injury: never studied directly.
Legal status
A supplement in some countries, a medicine in others. Not on the WADA list.
No anecdote collected yet.
Data console
Lab data
Heubi JE, Wiechmann DA, Creutzinger V . Tauroursodeoxycholic acid (TUDCA) in the prevention of total parenteral nutrition-associated liver disease.. The Journal of pediatrics.
Pan XL, Zhao L, Li L . Efficacy and safety of tauroursodeoxycholic acid in the treatment of liver cirrhosis: a double-blind randomized controlled trial.. Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban.
Song G, Weng F, Zou B . Potential therapeutic action of tauroursodeoxycholic acid against cholestatic liver injury via hepatic Fxr/Nrf2 and CHOP-DR5-caspase-8 pathway.. Clinical science (London, England : 1979).
Liong S, Lappas M . Endoplasmic reticulum stress regulates inflammation and insulin resistance in skeletal muscle from pregnant women.. Molecular and cellular endocrinology.
Safety
Side effects, stop signs, contraindications
Side effects · 3
- Diarrhea and loose stools: the most common complaint, dose-dependent, and usually eased by splitting the daily dose.
- Abdominal discomfort and bloating, typically in the first days of treatment.
- Rarely nausea. Serious adverse effects are not typical within the studied dose range, and the safety profile is favourable.
Contraindications · 3
- Complete biliary obstruction: bile acid preparations are contraindicated, and the diagnosis must be made by a physician.
- Acute cholecystitis or gallstone-induced biliary colic.
- Pregnancy and breastfeeding: human safety data are limited.
Related Performance Compounds
Same therapeutic category
Studies
Related research and clinical findings
Tauroursodeoxycholic acid (TUDCA) in the prevention of total parenteral nutrition-associated liver disease.
Heubi JE, Wiechmann DA, Creutzinger V
Efficacy and safety of tauroursodeoxycholic acid in the treatment of liver cirrhosis: a double-blind randomized controlled trial.
Pan XL, Zhao L, Li L
Potential therapeutic action of tauroursodeoxycholic acid against cholestatic liver injury via hepatic Fxr/Nrf2 and CHOP-DR5-caspase-8 pathway.
Song G, Weng F, Zou B
Endoplasmic reticulum stress regulates inflammation and insulin resistance in skeletal muscle from pregnant women.
Liong S, Lappas M
Telegram
Have a question about TUDCA (Tauroursodeoxycholic acid)?
Reach out to an advisor on Telegram. Performance compounds are presented with a harm-reduction approach, based on peer-reviewed evidence.
Personalized consultation
Want a detailed conversation tailored to your data?
Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.
Fill out the form~5–7 min · prep questionnaire · confidential · GDPR-compliant
The information here is for educational and scientific purposes only. Performance-enhancing compounds (AAS, prohormones, stimulants, doping agents) are illegal without prescription in Hungary and most of the EU, and carry serious health and legal risks. WADA bans them in competitive sport. This is NOT a usage guide, and we do not encourage any illegal use. If you do use them, medical supervision and regular bloodwork are ESSENTIAL. Severe endocrine, cardiovascular, hepatic and psychiatric side effects are possible.